In fact, among Medicare beneficiaries aged 65 years or older, the incidence of transthyretin cardiac amyloidosis (ATTR-CM) diagnoses rose from about 10.1 per 100,000 person-years ...

Brandon-based functional neurology clinic introduces a structured fly-in rehabilitation program for post-concussion ...

Water rarely gets the spotlight in conversations about health and wellbeing. We talk about superfoods, supplements, and exercise trends — yet hydration underpins them all. For people living with ...

In this letter, I’m going to offer a possible way of thinking about long COVID symptoms and how to treat them.

Five take-home messages for GPs on the recognition and management of attention deficit hyperactivity disorder (ADHD) in ...

TONMYA (cyclobenzaprine HCl sublingual tablets) for the treatment of fibromyalgia in adults, was commercially launched in November 2025Treatment ...

Company launched TONMYA, approved by the FDA as a treatment for fibromyalgia, in November 2025 In post hoc analysis of the pivotal RESILIENT study, TONMYA produced rapid pain relief as early as Day 2 ...

TONMYA™ (cyclobenzaprine HCl sublingual tablets) launched November 17, 2025, for the treatment of fibromyalgia; through February 27, 2026, more than 1,500 healthcare providers have prescribed TONMYA ...

Acid reflux happens when stomach contents flow back into the esophagus. Eating smaller meals helps prevent acid reflux symptoms. Avoiding smoking may decrease acid reflux frequency. Acid reflux, or ...

Treatment with TONMYA provided statistically significant pain reduction in two Phase 3 trials and was generally well tolerated BERKELEY HEIGHTS, N.J., March 09, 2026 (GLOBE NEWSWIRE) -- Tonix ...

TONMYA (cyclobenzaprine HCl sublingual tablets) launched November 17, 2025, for the treatment of fibromyalgia; through February 27, 2026, more than 1,500 healthcare providers have prescribed TONMYA to ...

Detailed price information for Tonix Pharm Holdings (TNXP-Q) from The Globe and Mail including charting and trades.